Bladder Cancer Detection May Get Easier With a Simple, Painless Urine Test

A home-based urine test could offer a simpler way to identify bladder cancer and help doctors decide which patients need further invasive testing. Early results from an NHS trial suggest the test was able to detect 92% of bladder cancer cases.

The findings, published in European Urology Oncology, come from research led by the University of Birmingham and diagnostics company Nonacus. Almost 1,000 patients from seven hospitals in England and Scotland took part in the trial.

HOW THE URINE TEST DETECTS BLADDER CANCER

The test, called Galeas, analyses a urine sample for genetic changes released by bladder cancer cells. It examines more than 450 DNA mutations associated with the disease across 23 genes.

Researchers at the University of Birmingham originally developed the test with support from Cancer Research UK. It was subsequently commercialised by Nonacus.

During the NHS study, Galeas detected 92% of bladder cancer cases. The researchers also found that when the test produced a negative result, there was a greater than 99% chance that the patient did not have bladder cancer.

That result could make the test particularly valuable as a way of ruling out the disease in patients considered to be at lower risk, potentially reducing the number of people sent for unnecessary invasive investigations.

WHO SHOULD BE ALERT TO BLADDER CANCER?

Bladder cancer is more frequently diagnosed in older adults and is particularly common among men over 60.

One of the most noticeable warning signs is blood in the urine. Depending on the amount of blood present, urine can appear pink, red or brown.

The seriousness of bladder cancer depends on several factors, including the characteristics and size of the tumour and whether it has spread to other parts of the body. Detecting the disease early can improve the chances of successful treatment.

CAN THE URINE TEST REPLACE CYSTOSCOPY?

Cystoscopy remains a key procedure for investigating suspected bladder cancer. It involves inserting a thin camera-equipped tube through the urethra and into the bladder, allowing doctors to directly inspect the bladder lining.

Although cystoscopy is an important diagnostic tool, it can be uncomfortable and invasive. The Galeas test could eventually help doctors determine which patients need a cystoscopy urgently and which may be able to avoid or postpone the procedure after receiving a negative result.

If future research confirms the test’s accuracy, it could potentially reduce the number of unnecessary cystoscopies and spare large numbers of patients from invasive examinations.

PROMISING RESULTS, BUT MORE TESTING NEEDED

The findings are encouraging, but the urine test is still undergoing evaluation and should not currently be viewed as a replacement for established diagnostic procedures.

Larger trials involving more diverse groups of patients will be needed to confirm how accurately the test performs in routine clinical settings and whether it can be safely incorporated into standard bladder-cancer care.

Until then, people who notice blood in their urine or develop other possible symptoms should consult a doctor. A negative urine test should not be used as a substitute for medical assessment or recommended follow-up tests.